VRE and MRSA Antibiotic Market Revenue 2024 to 2034
VRE and MRSA Antibiotic Market Revenue 2024 to 2034
The VRE and MRSA antibiotic market, valued at USD 2.34 billion in 2024, is projected to hit USD 3.84 billion by 2034, growing at 5.1% CAGR, driven by increasing prevalence of antibiotic-resistant infections.
Report ID: 10470
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 2.34 Bn
Forecast Year,
USD 3.85 Bn
CAGR, 2025 -
5.10%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
VRE and MRSA Antibiotic Market Size Analysis
VRE and MRSA Antibiotic Market Size By Drug 2024 to 2034 (USD )
| Drug | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Linezolid | 1.30 | 1.41 | 1.47 | 1.52 | 1.71 | 1.85 | 1.97 | 2.06 | 2.14 | 2.22 | 2.29 |
| Daptomycin | 0.41 | 0.52 | 0.53 | 0.55 | 0.57 | 0.62 | 0.62 | 0.63 | 0.60 | 0.59 | 0.66 |
| Vancomycin | 0.16 | 0.12 | 0.15 | 0.13 | 0.03 | 0.03 | 0.03 | 0.05 | 0.09 | 0.16 | 0.36 |
| Other | 0.47 | 0.41 | 0.43 | 0.51 | 0.55 | 0.50 | 0.53 | 0.57 | 0.65 | 0.70 | 0.55 |
VRE and MRSA Antibiotic Market Size By Route 2024 to 2034 (USD )
| Route | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Injectable | 1.56 | 1.63 | 1.68 | 1.76 | 1.91 | 2.02 | 2.16 | 2.20 | 2.29 | 2.42 | 2.43 |
| Oral | 0.78 | 0.83 | 0.91 | 0.96 | 0.94 | 0.98 | 0.99 | 1.12 | 1.19 | 1.24 | 1.41 |
VRE and MRSA Antibiotic Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 1.27 | 1.33 | 1.38 | 1.51 | 1.50 | 1.54 | 1.64 | 1.74 | 1.88 | 1.96 | 2.08 |
| Clinics | 0.65 | 0.70 | 0.76 | 0.85 | 0.95 | 1.08 | 1.11 | 1.15 | 1.21 | 1.30 | 1.36 |
| Others | 0.42 | 0.43 | 0.45 | 0.36 | 0.40 | 0.38 | 0.41 | 0.43 | 0.40 | 0.40 | 0.41 |
VRE and MRSA Antibiotic Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.45 | 0.47 | 0.45 | 0.49 | 0.48 | 0.56 | 0.64 | 0.72 | 0.72 | 0.77 | 0.83 |
| Europe | 0.28 | 0.39 | 0.45 | 0.40 | 0.35 | 0.38 | 0.33 | 0.38 | 0.40 | 0.42 | 0.50 |
| Asia Pacific | 0.41 | 0.40 | 0.45 | 0.51 | 0.50 | 0.52 | 0.55 | 0.47 | 0.52 | 0.67 | 0.74 |
| Latin America | 0.60 | 0.55 | 0.54 | 0.54 | 0.58 | 0.53 | 0.45 | 0.48 | 0.49 | 0.46 | 0.43 |
| Middle East & Africa | 0.60 | 0.66 | 0.69 | 0.78 | 0.95 | 1.02 | 1.19 | 1.26 | 1.35 | 1.34 | 1.35 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
